ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment AgreementPatent Assignment Agreement • July 7th, 2021 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledJuly 7th, 2021 Company Industry• Provides exclusive world-wide patent rights to the use of rNAPc2 as a potential treatment for COVID‑19 and other indications
ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment AgreementPatent Assignment Agreement • July 6th, 2021
Contract Type FiledJuly 6th, 2021• Provides exclusive world-wide patent rights to the use of rNAPc2 as a potential treatment for COVID-19 and other indications